The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
Stephen Friend is out at Apple's health team, after just over a year at the company, according to people familiar with the matter.
Friend's specialty involves rethinking health care research, with a focus on creating open incentives and standards that benefit patients. That was the mission of Sage Bionetworks, a non-profit that he co-founded in 2009 as a spinout of Merck.
Friend is also a cancer researcher, and he served on the faculty at Harvard Medical School.
The news that he joined Apple in 2016 to work on the "health-related projects" caused waves in the health industry given his stature. Apple at the time had introduced software frameworks -- ResearchKit, CareKit and HealthKit -- which are designed to help developers and consumers access health information.
These software kits required Apple to meet rigorous standards around security, privacy and consent, which are within Friend's realm of expertise.
Since then, Apple has launched a medical records beta with the support of a dozen leading hospitals to aggregate all of this health information in one place. It has also hired Sumbul Desai, a former executive director of Stanford's center for digital health.
Another member of Apple's health team, Anil Sethi, also left the company at the end of 2017 to work on a start-up focused on gathering health information for cancer patients.
Apple's COO Jeff Williams is also passionate about health care. He recently said that he envisioned the future as "consumers owning their health data," which isn't the reality for millions of Americans today.
Friend did not respond to a request for comment from CNBC. However, his LinkedIn page has been updated to show that his tenure at Apple ended in November of 2017, and he now lists himself as an "independent entrepreneur."